Dendritic cell subsets in health and disease

被引:322
作者
Ueno, Hideki
Klechevsky, Eynav
Morita, Rimpei
Aspord, Caroline
Cao, Tinghua
Matsui, Toshimichi
Di Pucchio, Tiziana
Connolly, John
Fay, Joseph W.
Pascual, Virginia
Palucka, A. Karolina
Banchereau, Jacques
机构
[1] Baylor Inst Immunol Res, Dallas, TX 75204 USA
[2] Technion Israel Inst Technol, Haifa, Israel
[3] Baylor Univ, Sammons Canc Ctr, Dallas, TX USA
关键词
dendritic cells; subsets; human; diseases; phagocyte;
D O I
10.1111/j.1600-065X.2007.00551.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The dendritic cell (DC) system of antigen-presenting cells controls immunity and tolerance. DCs initiate and regulate immune responses in a manner that depends on signals they receive from microbes and their cellular environment. They allow the immune system to make qualitatively distinct responses against different microbial infections. DCs are composed of subsets that express different microbial receptors and express different surface molecules and cytokines. Our studies lead us to propose that interstitial (dermal) DCs preferentially activate humoral immunity, whereas Langerhans cells preferentially induce cellular immunity. Alterations of the DC system result in diseases such as autoimmunity, allergy, and cancer. Conversely, DCs can be exploited for vaccination, and novel vaccines that directly target DCs in vivo are being designed.
引用
收藏
页码:118 / 142
页数:25
相关论文
共 360 条
[1]   Recognition of tumor glycans by antigen-presenting cells [J].
Aarnoudse, CA ;
Vallejo, JJG ;
Saeland, E ;
van Kooyk, Y .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) :105-111
[2]   Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin [J].
Agrawal, A ;
Lingappa, J ;
Leppla, SH ;
Agrawal, S ;
Jabbar, A ;
Quinn, C ;
Pulendran, B .
NATURE, 2003, 424 (6946) :329-334
[3]   Characterization of human inducible costimulator ligand expression and function [J].
Aicher, A ;
Hayden-Ledbetter, M ;
Brady, WA ;
Pezzutto, A ;
Richter, G ;
Magaletti, D ;
Buckwalter, S ;
Ledbetter, JA ;
Clark, EA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4689-4696
[4]  
Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745
[5]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[6]   Tumor-specific killer cells in paraneoplastic cerebellar degeneration [J].
Albert, ML ;
Darnell, JC ;
Bender, A ;
Francisco, LM ;
Bhardwaj, N ;
Darnell, RB .
NATURE MEDICINE, 1998, 4 (11) :1321-1324
[7]   The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues [J].
Allavena, P ;
Sica, A ;
Vecchi, A ;
Locati, M ;
Sozzani, S ;
Mantovani, A .
IMMUNOLOGICAL REVIEWS, 2000, 177 :141-149
[8]   Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation [J].
Arens, R ;
Schepers, K ;
Nolte, MA ;
van Oosterwijk, MF ;
van Lier, RAW ;
Schumacher, TNM ;
van Oers, MHJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (11) :1595-1605
[9]   Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery [J].
Asavaroengchai, W ;
Kotera, Y ;
Mulé, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :931-936
[10]   Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development [J].
Aspord, Caroline ;
Pedroza-Gonzalez, Alexander ;
Gallegos, Mike ;
Tindle, Sasha ;
Burton, Elizabeth C. ;
Su, Dan ;
Marches, Florentina ;
Banchereau, Jacques ;
Palucka, A. Karolina .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (05) :1037-1047